Log in
Enquire now
Inhibrx

Inhibrx

Inhibrx is an antibodies, Fusion Proteins founded by Mark P. Lappe, Brendan P. Eckelman and Quinn Deveraux.

OverviewStructured DataIssuesContributors

Contents

inhibrx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Location
‌
La Jolla, Placentia, California
La Jolla
La Jolla
0
San Diego
San Diego
CEO
Mark P. Lappe
Mark P. Lappe
0
Founder
Mark P. Lappe
Mark P. Lappe
0
‌
Quinn Deveraux
0
‌
Brendan P. Eckelman
0
Legal Name
Inhibrx LLC
Number of Employees (Ranges)
51 – 200
Phone Number
+185879542200
Full Address
Torrey Pines Science Park 11025 N Torrey Pines Rd #200 La Jolla, CA 92037, USA0
Investors
City Hill Ventures
City Hill Ventures
DUNS Number
040859583
Total Funding Amount (USD)
70,000,000
Latest Funding Round Date
April 2020
Exchange
Nasdaq
Nasdaq
Patents Assigned (Count)
2
Country
United States
United States
0

Other attributes

Ticker Symbol
INBX
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Inhibrx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.